JACOB GARY S
SEC CIK 1266802 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OKYO | OKYO Pharma Ltd | Chief DEVELOPMENT Off, Dir | 112.4K | $54.9K | — | 3 | 2022-05-19 | 2026-07-21 |
Most active insiders at OKYO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CERRONE GABRIELE M | Dir, 10% | $67.6K | — |
| 2 | Mantelli Flavio | Chief MEDICAL Off | $28.0K | — |
| 3 | Dempsey Robert John | CEO, Dir | $23.1K | — |
| 4 | BRANCACCIO JOHN P | Dir | $7,385 | — |
| 5 | Patil Rajkumar V. | CSO | $5,011 | — |
| 6 | JACOB GARY S | Chief DEVELOPMENT Off, Dir | $4,900 | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-08-07 16:15 | 2026-07-21 | OKYO | OKYO Pharma Ltd | JACOB GARY S | Chief DEVELOPMENT Off, Dir | P - Purchase | $1.40 | +3,500 | 112.4K | +3% | +$4,900 |
| 2026-07-23 16:15 | 2026-07-21 | OKYO | OKYO Pharma Ltd | JACOB GARY S | Chief DEVELOPMENT Off, Dir | A - Grant | $1.40 | +3,500 | 112.4K | +3% | +$4,900 | |
| 2022-05-19 | 2022-05-19 | OKYO | OKYO Pharma Ltd | JACOB GARY S | CEO, Dir | P - Purchase | $4.00 | +12.5K | 12.5K | New | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations